Karleen Oberton - Hologic Insider

Hologic Inc -- USA Stock  

USD 43.46  0.39  0.89%

Corporate VP of Fin. and Accounting and Controller

We currently do not have informatin regarding Karleen Oberton. This executive tanure with Hologic Inc is not currenlty determined.
781 280-0669  www.hologic.com

Karleen Oberton Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 4.62 % which means that it generated profit of $4.62 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 30.67 % meaning that it created $30.67 on every $100 dollars invested by stockholders.
The company currently holds 3.38 B in liabilities with Debt to Equity (D/E) ratio of 121.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Hologic Inc has Current Ratio of 0.77 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Found 4 records

VP Since

Robert KlugQuest Diagnostics Incorporated
Susan LisaBoston Scientific Corporation

Entity Summary

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical solutions for women in the United States, Europe, the AsiaPacific, and internationally. Hologic Inc (HOLX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 5,333 people. Hologic is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Hologic Inc to your portfolio

Top Management

Hologic Inc Leadership Team
Wayne Wilson, Director
Namal Nawana, Director
Sally Crawford, Director
Jay Stein, Chairman, Ph.D
Stephen MacMillan, Chairman
Sanjay Prabhakaran, President
Claus Egstrand, President
Samuel Merksamer, Director
Christiana Stamoulis, Director, MBA
Robert McMahon, CFO
Jan Verstreken, President
Karleen Oberton, VP
Thomas West, President
Eric Compton, COO
Lawrence Levy, Director
Elaine Ullian, Director
Amy Wendell, Director
Scott Garrett, Director
Peter Valenti, President
Nancy Leaming, Director
John Griffin, Executive
Allison Bebo, President
Charles Dockendorff, Director
Michael Watts, President
Jonathan Christodoro, Director, MBA
Al Kildani, Director

Stock Performance

Hologic Performance Indicators